Related Experiment Video
Updated: Nov 5, 2025

10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
1.8K
Improving virtual screening results with MM/GBSA and MM/PBSA rescoring
1Institute of Molecular Biology, National Academy of Sciences of the Republic of Armenia, 0014, Yerevan, Armenia. h_sahakyan@mb.sci.am.
Journal of Computer-Aided Molecular Design
|May 13, 2021
Summary
Virtual screening (VS) improves drug design by identifying potential drug candidates. Rescoring docking results with MM/PB(GB)SA methods significantly enhances binding affinity prediction accuracy.
Area of Science:
- Computational chemistry
- Drug discovery
- Bioinformatics
Background:
- Virtual screening (VS) is crucial for computer-aided drug design, accelerating the identification of potential therapeutic ligands.
- Current VS methods often suffer from low accuracy in binding affinity prediction due to limitations of scoring functions.
- More rigorous binding affinity calculations are time-consuming, necessitating efficient rescoring strategies.
Purpose of the Study:
- To improve the accuracy of virtual screening by rescoring docking results.
- To evaluate the effectiveness of MM/PB(GB)SA methods for binding affinity rescoring.
- To provide a user-friendly program for rescoring VS results.
Main Methods:
- Performed virtual screening on three benchmark datasets.
- Employed energy minimization with MM/PB(GB)SA (molecular mechanics energies combined with the Poisson-Boltzmann or generalized Born and surface area) for rescoring.
- Utilized metrics such as AUC, EF, and BEDROC for performance evaluation.
Main Results:
- Rescoring with MM/PB(GB)SA methods led to essential improvements in binding energy prediction.
- Demonstrated significant enhancements in virtual screening accuracy.
- Validated the effectiveness of the proposed rescoring approach across benchmark sets.
Conclusions:
- MM/PB(GB)SA rescoring substantially improves the accuracy of virtual screening.
- The developed program, based on AmberTools, offers an efficient tool for enhancing VS results.
- This approach aids in reducing false positives and expediting the drug development pipeline.

